Perspective - Journal of Molecular Oncology Research (2023) Volume 7, Issue 6

Inhibiting the growth of extracranial germ cell tumours.

Abstract

Children, adolescents, and babies who develop Germ Cell Tumours (GCTs) have unique difficulties. Nearly 15% of cancers in adolescents and 3% of malignancies in children and young adults are GCTs. According to epidemiological and molecular data, GCTs in young children presumably belong to a different biologic category than GCTs in older adolescents and adults. Despite this distinction, paediatric GCTs are typically managed using multi-agent regimens based on cisplatin, much like those applied to adults.